Home/Filings/4/0001171843-14-005941
4//SEC Filing

Sucampo Pharmaceuticals, Inc. 4

Accession 0001171843-14-005941

CIK 0001365216operating

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:34 PM ET

Size

14.3 KB

Accession

0001171843-14-005941

Insider Transaction Report

Form 4
Period: 2014-12-15
Claiborne Cary J
Chief Financial Officer
Transactions
  • Sale

    Class A Common Stock

    2014-12-15$12.89/sh7,100$91,5192,864 total
  • Sale

    Class A Common Stock

    2014-12-16$12.91/sh42,900$553,8392,864 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2014-12-1642,90099,987 total
    Exercise: $4.07From: 2013-06-04Exp: 2021-10-17Class A Common Stock (42,900 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2014-12-15$4.07/sh+7,100$28,8979,964 total
  • Exercise/Conversion

    Class A Common Stock

    2014-12-16$4.07/sh+42,900$174,60345,764 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2014-12-157,100142,887 total
    Exercise: $4.07From: 2013-06-04Exp: 2021-10-17Class A Common Stock (7,100 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.75 to $13.05, inclusive. The reporting person undertakes to provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.75 to $13.15, inclusive. The reporting person undertakes to provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Issuer

Sucampo Pharmaceuticals, Inc.

CIK 0001365216

Entity typeoperating

Related Parties

1
  • filerCIK 0001365216

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:34 PM ET
Size
14.3 KB